Silverarc Capital Management, LLC Gilead Sciences, Inc. Transaction History

Silverarc Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $173,093 - $188,848	2,341 Added 3.87%	62,789 $4.71 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $24,171 - $27,570	318 Added 0.53%	60,448 $4.66 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $631,468 - $719,437	8,168 Added 15.72%	60,130 $4.99 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $3.24 Million - $4.65 Million	51,962 New	51,962 $4.46 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.